Cargando…

Novel Approaches for the Treatment of Alzheimer’s and Parkinson’s Disease

Neurodegenerative disorders affect around one billion people worldwide. They can arise from a combination of genomic, epigenomic, metabolic, and environmental factors. Aging is the leading risk factor for most chronic illnesses of old age, including Alzheimer’s and Parkinson’s diseases. A progressiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Van Bulck, Michiel, Sierra-Magro, Ana, Alarcon-Gil, Jesus, Perez-Castillo, Ana, Morales-Garcia, Jose A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6386829/ https://www.ncbi.nlm.nih.gov/pubmed/30743990 http://dx.doi.org/10.3390/ijms20030719

Ejemplares similares

C/EBPβ Regulates TFAM Expression, Mitochondrial Function and Autophagy in Cellular Models of Parkinson’s Disease
por: Sierra-Magro, Ana, et al.
Publicado: (2023)

Neuroprotective and Anti-Inflammatory Effects of Linoleic Acid in Models of Parkinson’s Disease: The Implication of Lipid Droplets and Lipophagy
por: Alarcon-Gil, Jesus, et al.
Publicado: (2022)

CCAAT/Enhancer binding protein β silencing mitigates glial activation and neurodegeneration in a rat model of Parkinson’s disease
por: Morales-Garcia, Jose A., et al.
Publicado: (2017)

Phosphodiesterase 7 Inhibition Preserves Dopaminergic Neurons in Cellular and Rodent Models of Parkinson Disease
por: Morales-Garcia, Jose A., et al.
Publicado: (2011)

A label-free biosensor based on graphene and reduced graphene oxide dual-layer for electrochemical determination of beta-amyloid biomarkers
por: Sethi, Jagriti, et al.
Publicado: (2020)

Biological and Pharmacological Characterization of Benzothiazole-Based CK-1δ Inhibitors in Models of Parkinson’s Disease
por: Morales-Garcia, José A., et al.
Publicado: (2017)

Pharmacoepigenomic Interventions as Novel Potential Treatments for Alzheimer’s and Parkinson’s Diseases
por: Teijido, Oscar, et al.
Publicado: (2018)

Resveratrol Derivatives as Potential Treatments for Alzheimer’s and Parkinson’s Disease
por: Arbo, Bruno Dutra, et al.
Publicado: (2020)

Therapeutic Approach to Alzheimer’s Disease: Current Treatments and New Perspectives
por: Pardo-Moreno, Teresa, et al.
Publicado: (2022)

Glycogen Synthase Kinase 3 Inhibitors in the Next Horizon for Alzheimer's Disease Treatment
por: Martinez, Ana, et al.
Publicado: (2011)

Metabolic Mechanisms Connecting Alzheimer’s and Parkinson’s Diseases: Potential Avenues for Novel Therapeutic Approaches
por: Colca, Jerry R., et al.
Publicado: (2022)

The Role of Microglia in Retinal Neurodegeneration: Alzheimer's Disease, Parkinson, and Glaucoma
por: Ramirez, Ana I., et al.
Publicado: (2017)

Editorial: Experimental and Innovative Approaches to Multi-Target Treatment of Parkinson's and Alzheimer's Diseases
por: Tikhonova, Maria A., et al.
Publicado: (2022)

Emerging Nanotechnology for Treatment of Alzheimer’s and Parkinson’s Disease
por: Li, Amanda, et al.
Publicado: (2021)

Early visual alterations in individuals at-risk of Alzheimer’s disease: a multidisciplinary approach
por: López-Cuenca, Inés, et al.
Publicado: (2023)

Editorial: Experimental and innovative approaches to multi-target treatment of Parkinson's and Alzheimer's diseases - Volume II
por: Tikhonova, Maria A., et al.
Publicado: (2023)

Validation of the cross-cultural dementia screening test in Alzheimer’s disease and Parkinson’s disease
por: Delgado-Álvarez, Alfonso, et al.
Publicado: (2023)

Current Treatment Options for Alzheimer's Disease and Parkinson's Disease Dementia
por: Szeto, Jennifer Y.Y., et al.
Publicado: (2016)

Target Enzymes Considered for the Treatment of Alzheimer's Disease and Parkinson's Disease
por: Kim, Namdoo, et al.
Publicado: (2020)

Metabolic alterations in plasma from patients with familial and idiopathic Parkinson’s disease
por: Yakhine-Diop, Sokhna M.S., et al.
Publicado: (2020)

Shared cerebral metabolic pathology in non-transgenic animal models of Alzheimer's and Parkinson's disease
por: Barilar, Jelena Osmanovic, et al.
Publicado: (2020)

PPARs and Their Neuroprotective Effects in Parkinson’s Disease: A Novel Therapeutic Approach in α-Synucleinopathy?
por: Pérez-Segura, Isaac, et al.
Publicado: (2023)

Incretin and insulin signaling as novel therapeutic targets for Alzheimer’s and Parkinson’s disease
por: Nowell, Joseph, et al.
Publicado: (2022)

Induced Pluripotent Stem Cells for Treatment of Alzheimer’s and Parkinson’s Diseases
por: Yefroyev, David A, et al.
Publicado: (2022)

Roughness of retinal layers in Alzheimer’s disease
por: Jáñez-García, Lucía, et al.
Publicado: (2021)

Extracellular vesicles in the study of Alzheimer's and Parkinson's diseases: Methodologies applied from cells to biofluids
por: Vaz, Margarida, et al.
Publicado: (2022)

Treatment of Dysphagia in Parkinson’s Disease: A Systematic Review
por: López-Liria, Remedios, et al.
Publicado: (2020)

Data-Driven Approaches Used for Compound Library Design for the Treatment of Parkinson’s Disease
por: Barrera-Vazquez, Oscar, et al.
Publicado: (2023)

Current approaches to the treatment of Parkinson’s disease
por: Jankovic, Joseph, et al.
Publicado: (2008)

Emerging Treatment Approaches for Parkinson’s Disease
por: Stoker, Thomas B., et al.
Publicado: (2018)

New flavonoid – N,N-dibenzyl(N-methyl)amine hybrids: Multi-target-directed agents for Alzheimer´s disease endowed with neurogenic properties
por: Estrada-Valencia, Martín, et al.
Publicado: (2019)

Gold and silver nanoparticles in Alzheimer's and Parkinson's diagnostics and treatments
por: Scarpa, Edoardo, et al.
Publicado: (2023)

Untangling the Tauopathy for Alzheimer’s disease and parkinsonism
por: Chang, Hui-Yun, et al.
Publicado: (2018)

Genetic networks in Parkinson’s and Alzheimer’s disease
por: Kelly, Jack, et al.
Publicado: (2020)

Alzheimer's and Parkinson's disease therapies in the clinic
por: Chopade, Puja, et al.
Publicado: (2022)

Editorial: Highlights in Alzheimer's and Parkinson's disease
por: Cantone, Mariagiovanna, et al.
Publicado: (2023)

A Novel Treatment Strategy by Natural Products in NLRP3 Inflammasome-Mediated Neuroinflammation in Alzheimer’s and Parkinson’s Disease
por: Lee, Jun Ho, et al.
Publicado: (2021)

New drug treatments show neuroprotective effects in Alzheimer's and Parkinson's diseases
por: Hölscher, Christian
Publicado: (2014)

Parkinson's and Alzheimer's diseases in Costa Rica: a feasibility study toward a national screening program
por: Wesseling, Catharina, et al.
Publicado: (2013)

Multimodal Early Alzheimer’s Detection, a Genetic Algorithm Approach with Support Vector Machines
por: Sánchez-Reyna, Ana G., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cllcgvlb9i4s3idt8cmfonqhjd